Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Massachusetts | Superficial venous ablation · New York | |
|---|---|---|
| Surgeons, 2024 | 31 | 132 |
| Medicare fee-for-service cases | 1,623 | 8,630 |
| Growth since 2019 (Medicare FFS) | −5%/yr | −5.2%/yr |
| Forecast cases (Medicare FFS) | 1,600 in 2030 | 9,880 in 2030 |
| Forecast growth | −0.3%/yr to 2030 | +2.3%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.7 | 4.5 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 94% (+2 pts since 2019) | 97% (−0 pts since 2019) |
| Cases per surgeon | 52 | 65 |
| Top 10 surgeons' share | 60% | 25% |
| Surgeons growing | 4 | 19 |
| New since the base year | 10 | 43 |
| Likely to stop billing it | 6 by 2026 | 23 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $450 | $578 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.